Activities

The purpose of this education activity is to educate dermatology providers on:  

•  The importance of African American and Latino patient participation in lupus clinical trials. 

• The lack of participation by these minorities in clinical trials.

• How to help recruit these minorities with lupus into clinical trials.  

Activity Overview

The purpose of this activity is to educate nephrology providers on:   

•  The importance of African American and Latino patient participation in lupus clinical trials

• The lack of participation by these minorities in clinical trials

• Ways to help recruit these minorities with lupus into clinical trials

Target Audience

Nephrology providers including MDs, DOs, PAs, NPs, RNs; advanced practice nurses; and other medical providers who work in nephrology.

Registration is complimentary.

Learning Objectives

Upon completion of this activity, participants should be able to:

• Discuss lupus-related health disparities 

• Recognize provider barriers to clinical trial recruitment 

• Implement communication strategies between providers and patients about clinical trials

• Recognize simplified approaches to learn about local clinical trials for your patients

CE & MOC Information

• Credit must be claimed by October 27, 2028, at 11:59 PM ET.  

• By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board. 

• After submitting a reflective statement with key takeaways from the activity, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.

• All participating healthcare professionals should claim only the credit commensurate with the extent of their participation in this activity. 

Available Credit

• AMA PRA Category 1 Credit(s)™: 1.00

• ABIM MOC: 1.00 Medical Knowledge Points

Accreditation Statement

In support of improving patient care, the American College of Rheumatology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Provider Number: 0003797

See the ACR's CE Mission Statement. For more information, download the AMA PRA Booklet. 

AMA Designation Statement

The American College of Rheumatology designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Recognition Statement: American Board of Internal Medicine (ABIM)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Financial Relationship Disclosures

ACR Disclosure Statement

It is the policy of the American College of Rheumatology (ACR) to ensure thatContinuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.

Nature of Financial Relationships

All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:

1. Advisor or review panel member

2. Consultant

3. Employee

4. Officer or Board Member

5. Grant/research support

6. Speaker/honoraria includes speaker’s bureau, symposia, and expert witness

7. Independent contractor

8. Executive role and/or ownership interest

9. Royalties and/or patent beneficiary

10. Intellectual property/patents

11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan

12. Private investigator

13. Expert witness

14. Equity interest

15. Other: specify details 

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated.

• Allen Anandarajah, MD, MS: None  - Reviewer 

• Irene Blanco, MD: Novartis6 - Planner 

• Donna Culton, MD, PhD: Alkahest2, Argenx2,  Aria2, Kezar2, Principia5, Cabaletta5 - Planner

• Titilola Falasinnu, PhD: None  - Planner 

• Candace Feldman, MD: None - Reviewer 

• TramAnh Phan, MD: None - Planner 

• Kimberly DeQuattro, MD: None - Reviewer

• Rosalind Ramsey-Goldman, MD, DrPH: Aurinia2, AstraZeneca6, Biogen2, ThermoFisher2 - Planner 

• Wendy Rodgers, MPH: None - Reviewer  

• Saira Sheikh, MD: GlaxoSmithKline2; Aurinia Pharmaceuticals, Inc.2; AstraZeneca2; Lilly USA, LLC2; Pfizer5 - Planner 

• Kimberly Trotter,MD: None  - Planner

Acknowledgement of Commercial Support

This activity is supported by the U.S. Department of Health and Human Services, Office of Minority Health (HHS, OMH) with Grant Numbers 1 CPIMP171138 and 1 CPIMP18116. The activity content was provided by the author(s) and does not necessarily represent the official views of, nor an endorsement by, the OMH/HHS or U.S. Government.

Educational Activity Policies

See ACR educational activity policies, including the online enduring activity refund policy.